醫(yī)學(xué)免費(fèi)論文:HPV16�睧6蛋白在宮頸病變組織中的表達(dá)及臨床應(yīng)用

17 靳雙玲，趙澤燕，邊肖海.血管內(nèi)皮生長(zhǎng)因子�睠、高危型人乳頭瘤病毒在子宮頸上皮內(nèi)瘤樣病變及子宮頸鱗癌中的表達(dá)和意義.腫瘤研究一臨床雜志，2006，18：615��618.

18 Branca F，Giorgi C，Santini D，et al. Aberrant expression of VEGF�睠 is related to grade of cervical intraepithelial neoplasin(CN) and high risk HPV，but does not predict virus clearance after treatment of CN or prognosis of cervical cancer.J Clin Pathol，2006，59：40��47.

19 Sherman ME，Schiffman M，Cox JT，et al.Effects of age and human pap illoma viral load on colposcopy triage： data from the randomized atyp ical squamous cells of undetermined significance/ lowgrade squamous intraep ithelial lesion triage study (ALTS).J Natl Cancer Inst，2002，94：1022��1071.

20 Moberg M，gustavsson I，Wilander E，et al.High viral loads of human papillomavirus predict risk of invasive cervical carcinoma.Br J Cancer，2005，92：891��894.

21 Joura EA，Leodolter S，Hemandez�睞vila M，et al.Efficacy of a quadrivalent prophylactic human papillomavirus (types 6，11，16 and 18) L1 virus�瞝ike�瞤article vaccine against high�瞘rade vulval and vaginal lesions：a combined analysis of three randomized clinical trials.Lancet，2007，369：1693��1702.

22 Keam SJ，Harper DM.Human papillomavirus types 16 and 18 vaccine (recombinant，AS04 adjuvanted，adsorbed)[Cervarix].Drugs，2008，68：359��372.

上一頁(yè)  [1] [2] [3] [4] [5]  下一頁(yè)